147 related articles for article (PubMed ID: 16603167)
1. Conventional and experimental treatment of cerebral malaria.
Golenser J; McQuillan J; Hee L; Mitchell AJ; Hunt NH
Int J Parasitol; 2006 May; 36(5):583-93. PubMed ID: 16603167
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory effect of Sambucol on leishmanial and malarial infections.
Waknine-Grinberg JH; El-On J; Barak V; Barenholz Y; Golenser J
Planta Med; 2009 May; 75(6):581-6. PubMed ID: 19214946
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Higgins SJ; Kain KC; Liles WC
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
[TBL] [Abstract][Full Text] [Related]
6. Management of malaria: recent trends.
Mehta SR; Das S
J Commun Dis; 2006 Mar; 38(2):130-8. PubMed ID: 17370675
[TBL] [Abstract][Full Text] [Related]
7. Experience on loading dose--quinine therapy in cerebral malaria.
Mehta SR; Lazar AI; Kasthuri AS
J Assoc Physicians India; 1994 May; 42(5):376-8. PubMed ID: 7829436
[TBL] [Abstract][Full Text] [Related]
8. Cerebral malaria: what is known and what is on research.
Gay F; Zougbédé S; N'dilimabaka N; Rebollo A; Mazier D; Moreno A
Rev Neurol (Paris); 2012 Mar; 168(3):239-56. PubMed ID: 22386676
[TBL] [Abstract][Full Text] [Related]
9. Oxygen therapy for cerebral malaria.
Bruce-Hickman D
Travel Med Infect Dis; 2011 Sep; 9(5):223-30. PubMed ID: 21807563
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of artemisone for the treatment of experimental cerebral malaria.
Golenser J; Buchholz V; Bagheri A; Nasereddin A; Dzikowski R; Guo J; Hunt NH; Eyal S; Vakruk N; Greiner A
Parasit Vectors; 2017 Mar; 10(1):117. PubMed ID: 28249591
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on the mechanism of action of artemisinins.
Golenser J; Waknine JH; Krugliak M; Hunt NH; Grau GE
Int J Parasitol; 2006 Dec; 36(14):1427-41. PubMed ID: 17005183
[TBL] [Abstract][Full Text] [Related]
12. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.
Mimche PN; Taramelli D; Vivas L
Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21411011
[TBL] [Abstract][Full Text] [Related]
13. [Neurologic complications of malaria infection].
Hamann G; Schimrigk K
Fortschr Neurol Psychiatr; 1993 Feb; 61(2):46-54. PubMed ID: 8449477
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Pascual A; Desgrouas C; Travaillé C; Pradines B
Malar J; 2013 Aug; 12():302. PubMed ID: 23988087
[TBL] [Abstract][Full Text] [Related]
15. [Severe malaria: assessment of the treatment of anaemia and cerebral manifestations in a tropical intensive cares unit].
Gbadoé AD; Lawson-Evi K; Badayodi A; Géraldo A; Guédénon J; Akpako P; Agbéko F; Atakouma DY
Arch Pediatr; 2006 Dec; 13(12):1554-5. PubMed ID: 17029763
[No Abstract] [Full Text] [Related]
16. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
17. Cerebral malaria.
Garg RK
J Assoc Physicians India; 2000 Oct; 48(10):1004-13. PubMed ID: 11200901
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenesis of cerebral malaria.
Hunt NH; Golenser J; Chan-Ling T; Parekh S; Rae C; Potter S; Medana IM; Miu J; Ball HJ
Int J Parasitol; 2006 May; 36(5):569-82. PubMed ID: 16678181
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive therapy for severe malaria: a review and critical appraisal.
Varo R; Crowley VM; Sitoe A; Madrid L; Serghides L; Kain KC; Bassat Q
Malar J; 2018 Jan; 17(1):47. PubMed ID: 29361945
[TBL] [Abstract][Full Text] [Related]
20. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
